Related Experiment Videos
Immunohistochemical localization of p21(WAF1/CIP1) in normal, hyperplastic, and neoplastic uterine tissues
J P Palazzo1, W E Mercer, A J Kovatich
1Department of Pathology, Jefferson Medical College, Philadelphia, PA, USA.
Abstract:
p21WAF1/CIP1 is a nuclear protein that binds to cyclin-dependent kinase complexes (CDKs) and inhibits the activity of multiple kinases. These CDKs are involved in the regulation of cell cycle progression at several checkpoints. In this study, the authors have analyzed by immunohistochemistry the expression of p21WAF1/CIP1 in normal uterine tissues, 12 endometrial hyperplasias, 17 endocervical adenocarcinomas, and 31 endometrial adenocarcinomas. In addition, a group of 10 leiomyomas and 10 uterine leiomyosarcomas were also stained. To evaluate cell proliferation, the monoclonal antibody Ki-67 was used in all of the available cases. Terminally differentiated epithelial endocervical and endometrial cells showed variable expression of p21WAF1/CIP1, whereas the endometrial hyperplasias, and endocervical and endometrial adenocarcinomas showed decreased expression or were negative. All of the cases of cervical squamous dysplasia were positive. Normal smooth muscle cells and 50% of leiomyomas were negative, whereas all leiomyosarcomas showed expression of p21WAF1/CIP1. These results indicate that p21WAF1/CIP1 contributes to differentiation in normal endometrial and endocervical glands. The decreased expression of p21WAF1/CIP1 in endometrial hyperplasias and carcinomas may be important in the process of neoplastic transformation. The role of certain CDK inhibitors, such as p21WAF1/CIP1, is different in epithelial and mesenchymal tumorigenesis in the uterus.
Insights
The nuclear protein p21WAF1/CIP1 aids differentiation in normal uterine tissues but shows decreased expression in hyperplasias and carcinomas. Its role differs in epithelial versus mesenchymal uterine tumors.
Area of Science:
- Oncology
- Cell Biology
- Gynecologic Pathology
Background:
- p21WAF1/CIP1 is a nuclear protein that inhibits cyclin-dependent kinase (CDK) complexes, crucial for cell cycle regulation.
- CDKs play a vital role in cell cycle checkpoints, influencing cell proliferation and differentiation.
Purpose of the Study:
- To investigate the expression patterns of p21WAF1/CIP1 in various normal and neoplastic uterine tissues.
- To correlate p21WAF1/CIP1 expression with cell proliferation (Ki-67) and differentiation status in uterine lesions.
- To explore the differential roles of p21WAF1/CIP1 in epithelial and mesenchymal uterine tumorigenesis.
Main Methods:
- Immunohistochemistry was employed to analyze p21WAF1/CIP1 expression in normal uterine tissues, endometrial hyperplasias, endocervical adenocarcinomas, endometrial adenocarcinomas, leiomyomas, and leiomyosarcomas.
- The Ki-67 antibody was used to assess cell proliferation across all analyzed cases.
Main Results:
- Normal differentiated endocervical and endometrial cells exhibited variable p21WAF1/CIP1 expression.
- Endometrial hyperplasias, endocervical, and endometrial adenocarcinomas showed reduced or absent p21WAF1/CIP1 expression.
- Cervical squamous dysplasia cases were positive for p21WAF1/CIP1, while normal smooth muscle and 50% of leiomyomas were negative; all leiomyosarcomas were positive.
Conclusions:
- p21WAF1/CIP1 is implicated in the differentiation of normal endometrial and endocervical glands.
- Diminished p21WAF1/CIP1 expression may contribute to neoplastic transformation in endometrial hyperplasias and carcinomas.
- The function of p21WAF1/CIP1 in uterine tumorigenesis varies between epithelial and mesenchymal origins.